京东健康(06618.HK)拟3月5日举行董事会会议审批年度业绩

Core Viewpoint - JD Health (06618.HK) announced that it will hold a board meeting on March 5, 2026, to approve the annual performance for the year ending December 31, 2025, and to consider the proposal for the final dividend payment, if any [1] Group 1 - The board meeting is scheduled for March 5, 2026 [1] - The meeting will focus on approving the annual performance of the company and its subsidiaries for the year ending December 31, 2025 [1] - The board will also consider the proposal for the final dividend payment [1]